ANXA10 and thyroid gland papillary carcinoma: Conversely, in papillary thyroid cancer, the knockdown of ANXA10 promotes apoptosis by inhibiting the MAPK/ERK signalling pathway through the downregulation of TSG101 (Liu et al., 2012; Wei and Zhu, 2021).